In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector

This publication has 27 references indexed in Scilit:

• Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine
  Gene Therapy, 2001
• Current role of gene therapy in head and neck cancer
  European Journal of Surgical Oncology, 2000
• Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53)
  Cancer Gene Therapy, 2000
• Polyethylenimine-based intravenous delivery of transgenes to mouse lung
  Gene Therapy, 1998
• Gene transfer with lipospermines and polyethylenimines
  Advanced Drug Delivery Reviews, 1998
• Nonviral Gene Delivery to the Rat Kidney with Polyethylenimine
  Human Gene Therapy, 1997
• Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Molecular staging of head and neck squamous carcinoma
  Cancer and Metastasis Reviews, 1996
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
  Proceedings of the National Academy of Sciences, 1995
• Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.
  Proceedings of the National Academy of Sciences, 1994